Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japanese Companies Create Joint Venture To Develop Drug Generics

This article was originally published in PharmAsia News

Executive Summary

Japanese firms Seven & i Holdings and Ain Phamaciez have agreed to establish a separate company in late May to develop generic drugs. Seven & i, which seeks to use the government's new emphasis on generics to expand its drug business, is to have a 10 percent stake and other firms in its group that operate drug stores is to own another 60 percent, with the remaining 30 percent to be owned by Ain. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts